Cell membrane-camouflaged nanoparticles for drug delivery

Journal of Controlled Release

Volumn 220, Issue , 2015, Pages 600-607

  Luk, Brian T ^a   Zhang, Liangfang ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Biomimetic nanoparticle; Cell membrane; Drug delivery; Nanomedicine; Targeted delivery

Indexed keywords

BIOMIMETICS; CELL MEMBRANES; CELLS; COATINGS; CYTOLOGY; DRUG DELIVERY; ENZYME INHIBITION; MEDICAL NANOTECHNOLOGY; MEMBRANES; NANOPARTICLES;

BIOMIMETIC NANOPARTICLES; COATED NANOPARTICLES; CONVENTIONAL METHODS; NATURAL BIOMATERIALS; SYNTHETIC NANOPARTICLES; SYSTEMIC CIRCULATION; TARGETED DELIVERY; THERAPEUTIC EFFICACY;

CELL ENGINEERING;

NANOPARTICLE; BIOMIMETIC MATERIAL; DRUG; DRUG CARRIER;

ARTICLE; CELL MEMBRANE; CELL SPECIFICITY; CHEMICAL REACTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; ANIMAL; BIOMIMETICS; CHEMISTRY; HUMAN; METABOLISM; NANOTECHNOLOGY; PHARMACOKINETICS;

ANIMALS; BIOMIMETIC MATERIALS; BIOMIMETICS; CELL MEMBRANE; DRUG CARRIERS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 84949538582     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.07.019     Document Type: Article

References (74)

1. S. Mitragotri, P.A. Burke, and R. Langer Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies Nat. Rev. Drug Discov. 13 2014 655 672
2. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S81 S91
3. O.C. Farokhzad, and R. Langer Nanomedicine: developing smarter therapeutic and diagnostic modalities Adv. Drug Deliv. Rev. 58 2006 1456 1459
4. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
5. B.T. Luk, and L. Zhang Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis ACS Appl. Mater. Interfaces 6 2014 21859 21873
6. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzym. Regul. 41 2001 189 207
7. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS Cancer Res. 46 1986 6387 6392
8. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
9. A.Z. Wang, R. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 63 2012 185 198
10. M.E. Davis, Z.G. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
11. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
12. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
13. S. Barua, and S. Mitragotri Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles ACS Nano 7 2013 9558 9570
14. S. Barua, J.W. Yoo, P. Kolhar, A. Wakankar, Y.R. Gokarn, and S. Mitragotri Particle shape enhances specificity of antibody-displaying nanoparticles Proc. Natl. Acad. Sci. U. S. A. 110 2013 3270 3275
15. P. Kolhar, A.C. Anselmo, V. Gupta, K. Pant, B. Prabhakarpandian, E. Ruoslahti, and S. Mitragotri Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium Proc. Natl. Acad. Sci. U. S. A. 110 2013 10753 10758
16. O.C. Farokhzad Using ligands to target cancer cells Clin. Adv. Hematol. Oncol. 10 2012 543 544
17. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, and R. Langer Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc. Natl. Acad. Sci. U. S. A. 103 2006 6315 6320
18. P.M. Valencia, M.H. Hanewich-Hollatz, W. Gao, F. Karim, R. Langer, R. Karnik, and O.C. Farokhzad Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles Biomaterials 32 2011 6226 6233
19. S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 2011 170 183
20. P.A. Gunatillake, and R. Adhikari Biodegradable synthetic polymers for tissue engineering Eur. Cell Mater. 5 2003 1 16
21. R.H. Fang, K.N. Chen, S. Aryal, C.M. Hu, K. Zhang, and L. Zhang Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor Langmuir 28 2012 13824 13829
22. J. Hrkach, D. Von Hoff, M. Mukkaram Ali, E. Andrianova, J. Auer, T. Campbell, D. De Witt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnarajan, A. Sabnis, E. Schnipper, J.J. Song, Y.H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van Geen Hoven, J. Wright, P. LoRusso, P.W. Kantoff, N.H. Bander, C. Sweeney, O.C. Farokhzad, R. Langer, and S. Zale Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 4 2012 128ra139
23. M. Rhee, P.M. Valencia, M.I. Rodriguez, R. Langer, O.C. Farokhzad, and R. Karnik Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels Adv. Mater. 23 2011 H79 H83
24. S. Eliasof, D. Lazarus, C.G. Peters, R.I. Case, R.O. Cole, J. Hwang, T. Schluep, J. Chao, J. Lin, Y. Yen, H. Han, D.T. Wiley, J.E. Zuckerman, and M.E. Davis Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle Proc. Natl. Acad. Sci. U. S. A. 110 2013 15127 15132
25. S. Svenson, M. Wolfgang, J. Hwang, J. Ryan, and S. Eliasof Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101 J. Control. Release 153 2011 49 55
26. M.E. Davis, J.E. Zuckerman, C.H. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, and A. Ribas Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 2010 1067 1070
27. D.W. Kim, S.Y. Kim, H.K. Kim, S.W. Kim, S.W. Shin, J.S. Kim, K. Park, M.Y. Lee, and D.S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Oncol. 18 2007 2009 2014
28. T.Y. Kim, D.W. Kim, J.Y. Chung, S.G. Shin, S.C. Kim, D.S. Heo, N.K. Kim, and Y.J. Bang Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 2004 3708 3716
29. S.C. Balmert, and S.R. Little Biomimetic delivery with micro- and nanoparticles Adv. Mater. 24 2012 3757 3778
30. D.J. Irvine, M.A. Swartz, and G.L. Szeto Engineering synthetic vaccines using cues from natural immunity Nat. Mater. 12 2013 978 990
31. R. Langer, and D.A. Tirrell Designing materials for biology and medicine Nature 428 2004 487 492
32. U.G. Wegst, H. Bai, E. Saiz, A.P. Tomsia, and R.O. Ritchie Bioinspired structural materials Nat. Mater. 14 2015 23 36
33. C.M. Hu, L. Zhang, S. Aryal, C. Cheung, and R.H. Fang Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform Proc. Natl. Acad. Sci. U. S. A. 108 2011 10980 10985
34. C.M. Hu, R.H. Fang, J. Copp, B.T. Luk, and L. Zhang A biomimetic nanosponge that absorbs pore-forming toxins Nat. Nanotechnol. 8 2013 336 340
35. C.M. Hu, R.H. Fang, B.T. Luk, and L. Zhang Nanoparticle-detained toxins for safe and effective vaccination Nat. Nanotechnol. 8 2013 933 938
36. W. Gao, C.M. Hu, R.H. Fang, and L. Zhang Liposome-like nanostructures for drug delivery J. Mater. Chem. B 1 2013 6569 6585
37. W. Gao, and L.F. Zhang Engineering red-blood-cell-membrane-coated nanoparticles for broad biomedical applications AIChE J. 61 2015 738 746
38. C.M. Hu, R.H. Fang, B.T. Luk, and L. Zhang Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies Nanoscale 6 2014 65 75
39. K. Knop, R. Hoogenboom, D. Fischer, and U.S. Schubert Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives Angew. Chem. Int. Ed. Engl. 49 2010 6288 6308
40. S. Jiang, and Z. Cao Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications Adv. Mater. 22 2010 920 932
41. W. Yang, L. Zhang, S. Wang, A.D. White, and S. Jiang Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum Biomaterials 30 2009 5617 5621
42. N. Doshi, A.S. Zahr, S. Bhaskar, J. Lahann, and S. Mitragotri Red blood cell-mimicking synthetic biomaterial particles Proc. Natl. Acad. Sci. U. S. A. 106 2009 21495 21499
43. T.J. Merkel, S.W. Jones, K.P. Herlihy, F.R. Kersey, A.R. Shields, M. Napier, J.C. Luft, H. Wu, W.C. Zamboni, A.Z. Wang, J.E. Bear, and J.M. DeSimone Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles Proc. Natl. Acad. Sci. U. S. A. 108 2011 586 591
44. P.L. Rodriguez, T. Harada, D.A. Christian, D.A. Pantano, R.K. Tsai, and D.E. Discher Minimal "self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles Science 339 2013 971 975
45. C.M. Hu, R.H. Fang, and L. Zhang Erythrocyte-inspired delivery systems Adv. Healthc. Mater. 1 2012 537 547
46. C.M. Hu, R.H. Fang, B.T. Luk, K.N. Chen, C. Carpenter, W. Gao, K. Zhang, and L. Zhang 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach Nanoscale 5 2013 2664 2668
47. B.T. Luk, C.M. Hu, R.H. Fang, D. Dehaini, C. Carpenter, W. Gao, and L. Zhang Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles Nanoscale 6 2014 2730 2737
48. W. Gao, C.M. Hu, R.H. Fang, B.T. Luk, J. Su, and L. Zhang Surface functionalization of gold nanoparticles with red blood cell membranes Adv. Mater. 25 2013 3549 3553
49. J.G. Piao, L. Wang, F. Gao, Y.Z. You, Y. Xiong, and L. Yang Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy ACS Nano 8 2014 10414 10425
50. L.L. Li, J.H. Xu, G.B. Qi, X. Zhao, F. Yu, and H. Wang Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery ACS Nano 8 2014 4975 4983
51. F. Gu, L. Zhang, B.A. Teply, N. Mann, A. Wang, A.F. Radovic-Moreno, R. Langer, and O.C. Farokhzad Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U. S. A. 105 2008 2586 2591
52. E.M. Pridgen, F. Alexis, T.T. Kuo, E. Levy-Nissenbaum, R. Karnik, R.S. Blumberg, R. Langer, and O.C. Farokhzad Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery Sci. Transl. Med. 5 2013 213ra167
53. R.H. Fang, C.M. Hu, K.N. Chen, B.T. Luk, C.W. Carpenter, W. Gao, S. Li, D.E. Zhang, W. Lu, and L. Zhang Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles Nanoscale 5 2013 8884 8888
54. S.K. Khaldoyanidi, V.V. Glinsky, L. Sikora, A.B. Glinskii, V.V. Mossine, T.P. Quinn, G.V. Glinsky, and P. Sriramarao MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions J. Biol. Chem. 278 2003 4127 4134
55. V.V. Glinsky, G.V. Glinsky, O.V. Glinskii, V.H. Huxley, J.R. Turk, V.V. Mossine, S.L. Deutscher, K.J. Pienta, and T.P. Quinn Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium Cancer Res. 63 2003 3805 3811
56. R.H. Fang, C.M. Hu, B.T. Luk, W. Gao, J.A. Copp, Y. Tai, D.E. O'Connor, and L. Zhang Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery Nano Lett. 14 2014 2181 2188
57. S. Aryal, C.M. Hu, and L. Zhang Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy Mol. Pharm. 8 2011 1401 1407
58. K. Hu, J. Li, Y. Shen, W. Lu, X. Gao, Q. Zhang, and X. Jiang Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations J. Control. Release 134 2009 55 61
59. J. Cheng, B.A. Teply, I. Sherifi, J. Sung, G. Luther, F.X. Gu, E. Levy-Nissenbaum, A.F. Radovic-Moreno, R. Langer, and O.C. Farokhzad Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28 2007 869 876
60. D.W. Miller, E.V. Batrakova, T.O. Waltner, V. Alakhov, and A.V. Kabanov Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption Bioconjug. Chem. 8 1997 649 657
61. B.T. Luk, R.H. Fang, and L. Zhang Lipid- and polymer-based nanostructures for cancer theranostics Theranostics 2 2012 1117 1126
62. S. Aryal, C.M. Hu, R.H. Fang, D. Dehaini, C. Carpenter, D.E. Zhang, and L. Zhang Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release Nanomedicine (London) 8 2013 1271 1280
63. S. Aryal, C.M. Hu, and L. Zhang Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery ACS Nano 4 2010 251 258
64. W. Gao, J.M. Chan, and O.C. Farokhzad pH-responsive nanoparticles for drug delivery Mol. Pharm. 7 2010 1913 1920
65. L. Zhang, J.M. Chan, F.X. Gu, J.W. Rhee, A.Z. Wang, A.F. Radovic-Moreno, F. Alexis, R. Langer, and O.C. Farokhzad Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform ACS Nano 2 2008 1696 1702
66. J. Lehar, A.S. Krueger, W. Avery, A.M. Heilbut, L.M. Johansen, E.R. Price, R.J. Rickles, G.F. Short III, J.E. Staunton, X. Jin, M.S. Lee, G.R. Zimmermann, and A.A. Borisy Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 27 2009 659 666
67. F. Calabro, V. Lorusso, G. Rosati, L. Manzione, L. Frassineti, T. Sava, E.D. Di Paula, S. Alonso, and C.N. Sternberg Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma Cancer 115 2009 2652 2659
68. H.M. McDaid, and P.G. Johnston Synergistic interaction between paclitaxel and 8-chloro-adenosine 3′,5′-monophosphate in human ovarian carcinoma cell lines Clin. Cancer Res. 5 1999 215 220
69. C.M. Hu, and L. Zhang Nanoparticle-based combination therapy toward overcoming drug resistance in cancer Biochem. Pharmacol. 83 2012 1104 1111
70. S. Aryal, C.M. Hu, and L. Zhang Combinatorial drug conjugation enables nanoparticle dual-drug delivery Small 6 2010 1442 1448
71. J.A. Copp, R.H. Fang, B.T. Luk, C.M. Hu, W. Gao, K. Zhang, and L. Zhang Clearance of pathological antibodies using biomimetic nanoparticles Proc. Natl. Acad. Sci. U. S. A. 111 2014 13481 13486
72. Z.Y. Fan, H. Zhou, P.Y. Li, J.E. Speer, and H. Cheng Structural elucidation of cell membrane-derived nanoparticles using molecular probes J. Mater. Chem. B 2 2014 8231 8238
73. W. Gao, R.H. Fang, S. Thamphiwatana, B.T. Luk, J. Li, P. Angsantikul, Q. Zhang, C.M. Hu, and L. Zhang Modulating antibacterial immunity via bacterial membrane-coated nanoparticles Nano Lett. 15 2015 1403 1409
74. A. Parodi, N. Quattrocchi, A.L. van de Ven, C. Chiappini, M. Evangelopoulos, J.O. Martinez, B.S. Brown, S.Z. Khaled, I.K. Yazdi, M.V. Enzo, L. Isenhart, M. Ferrari, and E. Tasciotti Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions Nat. Nanotechnol. 8 2013 61 68